Over the course of several months in 2021, The EPA’s Office of Research and Development (ORD), under the auspices of the EPA’s COVID-19 research program, evaluated the effectiveness of different technologies including Griganrd Pure® for reducing the level of SARS-CoV-2 virus particle in the air. This document presents the Summary Findings together with additional data and commentary provided by Grignard Pure®.

A report on the performance and efficacy of Grignard Pure® against an array of pathogens including viruses (MS2 and PHI 6 surrogates), bacteria (MRSA, salmonella, mycobacterium, and others), and
mold (aspergillus) as conducted by Aerosol Research Laboratories, Inc.

In May 2020, we contracted with a leading lab for airborne viral testing, to conduct rigorous tests on Grignard Pure®’s effectiveness and efficacy. The results show that Grignard Pure® kills more than 98% of the airborne virus particles. Reach out to us to request a full copy of the report.​​​​​​​

This peer-reviewed paper published in the February 2023 issue of Environmental Science & Technology, is authored by several members of Bleu Garde™’s Advisory Team and addresses the “Efficacy of Grignard Pure® to inactivate airborne

phage, MS2”

COVID-19 Research: Ozone and Aerosol Treatment. HSRP Webinar Series August 12, 2021. ORD’s Center for Environmental Solutions and Emergency Response.